Paraneoplastic Cerebellar Degeneration As Initial Symptom Of Renal Cell Carcinoma
Objective: To describe a case of paraneoplastic cerebellar degeneration in a patient with renal cell carcinoma. Background: Paraneoplastic cerebellar degeneration belongs to a group of…Pallidal surgery and physiological mechanism in choreic movements
Objective: To investigate the effect of deep brain stimulation (DBS) or coagulation of the internal globus pallidus (GPi) for choreic movements of various disorders and…The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
Objective: The aim of this study was (1) to investigate the prevalence of movement disorders in a large cohort of patients with encephalitis with LGI1…Association of genetic polymophisms with pharmacokinetics of levodopa in South indian PD patients
Objective: To evaluate the role of COMT gene variations on the pharmacokinetics (PK) of L-dopa in PD patients. Background: Genetic variations in enzymes (MAO-B, COMT),…Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite
Objective: To evaluate the behavioural changes in transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by different doses of Ropinirole alginate nanocomposite (RANC).…Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India
Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates
Objective: To assess clusters of neuropsychiatric symptoms in Parkinson’s disease and their relation to motor symptoms and demographic markers in a large PD cohort. Background:…Management of Patients with Functional Movement Disorders: A Transcultural Perspective
Objective: To compare the clinical management, available resources and barriers to care for patients with functional movement disorders (FMD) across 15 countries around the globe.…Evaluating IL6 and mitochondrial DNA levels as a potential biomarker in carriers of Parkin and PINK1 mutations
Objective: To discriminate affected PARK-Parkin and PARK-PINK1 mutation carriers from idiopathic Parkinson’s disease (PD) patients and healthy controls using serum IL-6 and mtDNA levels. Background:…Spastic Paraplegia Type 64: a Case Series
Objective: to present four cases (two families) with a likely diagnosis of spastic paraplegia type 64 (SPG 64), broadening this disease phenotype. Background: SPG64 is…
- « Previous Page
- 1
- …
- 127
- 128
- 129
- 130
- 131
- …
- 217
- Next Page »